![]() |
市场调查报告书
商品编码
1453852
免疫测量的全球市场 2024-2028Global Radioimmunoassay Market 2024-2028 |
2023-2028年免疫测量市场规模预估为17.3亿美元,预测期内复合年增长率为4.82%。
该报告包括对免疫测量市场的总体分析、市场规模/预测、趋势、成长动力、挑战以及涵盖约 25 家供应商的供应商分析。
它提供了对当前市场状况、最新趋势和驱动因素以及整体市场环境的最新分析。该市场是由製药和生物技术行业的扩张、感染疾病的流行以及老年人口的增加所推动的。
市场范围 | |
---|---|
基准年 | 2024年 |
结束年份 | 2028年 |
预测期 | 2024-2028 |
成长动力 | 加速度 |
2024年与前一年同期比较 | 3.83% |
复合年增长率 | 4.82% |
增量 | 17.3亿美元 |
研究指出,免疫测量系统的自动化和整合将是未来几年推动免疫测量市场成长的关键因素之一。此外,基于免疫测量的照护现场设备市场的开拓以及对个人化医疗的日益重视预计将带来巨大的市场需求。
The radioimmunoassay market is forecasted to grow by USD 1.73 bn during 2023-2028, accelerating at a CAGR of 4.82% during the forecast period. The report on the radioimmunoassay market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of pharmaceutical and biotechnology industries, rise in prevalence of infectious diseases, and growing geriatric population.
Technavio's radioimmunoassay market is segmented as below:
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 3.83% |
CAGR | 4.82% |
Incremental Value | $1.73bn |
By Application
By Product
By Geographical Landscape
This study identifies the shift towards automation and integration into radioimmunoassay systems as one of the prime reasons driving the radioimmunoassay market growth during the next few years. Also, development of radioimmunoassay-based point-of-care devices and increasing emphasis on personalized medicine will lead to sizable demand in the market.
The report on the radioimmunoassay market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radioimmunoassay market vendors that include ALPCO, Beckman Coulter Inc., Bio Rad Laboratories Inc., BioVendor Laboratorni medicina AS, Danaher Corp., Enzo Biochem Inc., Merck KGaA, MP BIOMEDICALS, OriGene Technologies Inc., PerkinElmer Inc, Siemens Healthineers AG, Tecan Trading AG, and Thermo Fisher Scientific Inc.. Also, the radioimmunoassay market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Exhibits: